Dinesh Purandare, SVP Global Oncology/Commercial at Radius Health, Inc. (RDUS), bought 200 shares at $62.20 ($12K) on 2015-08-31, disclosed to the SEC on 2015-09-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.